Engineers Gate Manager LP Makes New Investment in Solventum Corporation $SOLV

Engineers Gate Manager LP bought a new position in Solventum Corporation (NYSE:SOLV) in the 2nd quarter, Holdings Channel.com reports. The institutional investor bought 24,383 shares of the company’s stock, valued at approximately $1,881,000.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Integrated Wealth Concepts LLC grew its stake in Solventum by 7.1% in the 2nd quarter. Integrated Wealth Concepts LLC now owns 9,052 shares of the company’s stock valued at $698,000 after buying an additional 597 shares in the last quarter. NewEdge Advisors LLC lifted its position in shares of Solventum by 100.3% during the second quarter. NewEdge Advisors LLC now owns 13,437 shares of the company’s stock worth $1,037,000 after acquiring an additional 6,730 shares in the last quarter. IFP Advisors Inc lifted its position in shares of Solventum by 46.7% during the second quarter. IFP Advisors Inc now owns 1,075 shares of the company’s stock worth $83,000 after acquiring an additional 342 shares in the last quarter. Squarepoint Ops LLC boosted its holdings in shares of Solventum by 6,103.8% in the second quarter. Squarepoint Ops LLC now owns 243,128 shares of the company’s stock worth $18,757,000 after acquiring an additional 239,209 shares during the period. Finally, Beacon Investment Advisory Services Inc. grew its position in shares of Solventum by 11.8% in the second quarter. Beacon Investment Advisory Services Inc. now owns 8,327 shares of the company’s stock valued at $642,000 after purchasing an additional 877 shares in the last quarter.

Wall Street Analysts Forecast Growth

A number of brokerages recently issued reports on SOLV. BTIG Research reissued a “buy” rating and set a $95.00 price objective on shares of Solventum in a report on Monday. Weiss Ratings raised Solventum from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, August 18th. BMO Capital Markets began coverage on shares of Solventum in a report on Wednesday, July 8th. They issued a “market perform” rating and a $81.00 price target on the stock. Stifel Nicolaus raised their price objective on shares of Solventum from $90.00 to $100.00 and gave the company a “buy” rating in a research report on Thursday, August 6th. Finally, Wall Street Zen raised shares of Solventum from a “hold” rating to a “buy” rating in a report on Saturday. Eight analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Solventum has a consensus rating of “Moderate Buy” and an average target price of $92.80.

Solventum Stock Up 0.3%

Shares of NYSE SOLV opened at $90.06 on Wednesday. The company has a current ratio of 1.02, a quick ratio of 0.74 and a debt-to-equity ratio of 1.00. The business has a 50-day moving average of $85.66 and a 200-day moving average of $76.80. The firm has a market capitalization of $15.33 billion, a price-to-earnings ratio of 11.01, a PEG ratio of 1.40 and a beta of 0.61. Solventum Corporation has a 12 month low of $62.38 and a 12 month high of $94.16.

Solventum (NYSE:SOLV) last announced its earnings results on Wednesday, August 5th. The company reported $2.55 earnings per share for the quarter, beating analysts’ consensus estimates of $1.91 by $0.64. Solventum had a net margin of 17.26% and a return on equity of 25.09%. The business had revenue of $2.21 billion for the quarter, compared to the consensus estimate of $2.15 billion. During the same period last year, the firm posted $1.69 earnings per share. Solventum’s quarterly revenue was up 2.2% on a year-over-year basis. Solventum has set its FY 2026 guidance at 7.100-7.200 EPS. Sell-side analysts expect that Solventum Corporation will post 7.22 earnings per share for the current fiscal year.

Solventum Profile

Solventum Corporation (NYSE:SOLV) is a global healthcare company that develops products and technologies intended to improve patient care, support healthcare professionals and increase the efficiency of healthcare delivery. The company serves hospitals, clinics, dental practices, laboratories, government agencies and other healthcare-related organizations.

Its offerings include medical and surgical products such as wound-care, skin-care, infection-prevention and surgical solutions; dental products and materials; and health information systems that support clinical documentation, coding, workflow and decision-making.